Last checked at 25 Oct 2021 10:15
25 October 2021 |
|
This is a restatement of the announcement published at 16.35 on 22 October 2021 (RNS number 0078Q) correcting Mr Foster's interest in Ordinary Shares and his resultant shareholding in the Company. Mr Foster's interest in Ordinary Shares should have stated 3,755,283, representing approximately 5.51 per cent. of the Company's ordinary share capital. The restatement reflects an additional 500,000 Ordinary Shares held by Nia Foster, a person closely associated (PCA) with Toby Foster. The full corrected announcement is included below.
| |
INSPIRATION HEALTHCARE GROUP PLC
(the "Company")
Directors / PDMR Dealing
The Company has been notified that Toby Foster, VP Strategic Opportunities and a person discharging managerial responsibility ("PDMR") in the Company, on Thursday 21st October sold 25,000 ordinary shares of 10 pence each in the Company ("Ordinary Shares").
Following the sale, Mr Foster retains an interest in 3,755,283 Ordinary Shares, representing approximately 5.51 per cent. of the Company's issued ordinary share capital. Mr Foster's total interest in the Company includes 500,000 Ordinary Shares held by his wife, Nia Foster, a person closely associated (PCA). Mr Foster has indicated to the Company that he has no intention to sell further shares at this time.
This announcement, including the notification below, is made in accordance with the requirements of the EU Market Abuse Regulation.
1 |
| Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a. | Name |
| Toby Foster | ||||||||
2 | Reason for notification |
|
| ||||||||
a. | Position/Status |
| VP Strategic Opportunities of Inspiration Healthcare Group plc | ||||||||
b. | Initial notification/ Amendment |
| Initial Notification | ||||||||
3 |
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a. | Name |
| INSPIRATION HEALTHCARE GROUP PLC
| ||||||||
b. | LEI |
| 213800GKFT3ENAPMDL15 | ||||||||
4 |
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a. | Description of the financial instrument, type of instrumentIdentification Code |
| Ordinary Shares of 10p each
ISIN: GB00BXDZL105 | ||||||||
b. | Nature of the transaction |
| Sale of Ordinary Shares | ||||||||
c. | Price(s) and volume(s) |
|
|
|
|
|
| ||||
| Price(s) | Volume(s) | Date |
| |||||||
138p
| 25,000
| 21st October 2021 |
| ||||||||
|
| ||||||||||
d. | Aggregated information - Aggregated Volume - Price
|
|
| ||||||||
e. | Date of the transaction |
| 21st October 2021 | ||||||||
f. | Place of the transaction |
| XLON (AIM) | ||||||||
Enquiries:
Inspiration Healthcare Group plcNeil Campbell, Chief Executive OfficerJonathan Ballard, Chief Financial Officer | Tel: 01455 840 555
|
Cenkos Securities plc - Nominated Adviser & BrokerMark Connelly / Stephen Keys | Tel: 0207 397 8900
|
Cadogan PRAlex Waltersalex.walters@cadoganpr.com | Tel: 07771 713 608
|
About Inspiration Healthcare
Inspiration Healthcare (AIM: IHC) is a global provider of medical technology for use in critical care & operating theatres. The Company provides high quality innovative products to patients around the world which help to improve patient outcomes and it actively invests in innovative product opportunities and disruptive technologies.
Through investment in research and development the Company has 6 key own brand products that can be used within the first 6 hours of life to help premature and sick babies; helping with assessment, resuscitation, stabilisation as well as preventing brain damage. Additionally, the Company has its own range of products for maintaining normothermia pre- during and post-surgery.
With product availability extending to over 75 countries through a distribution network, Inspiration Healthcare's success has been built on continuous innovation, excellent customer service and an inherent commitment to improving patient outcomes, working in close collaboration with key opinion leaders across the globe.
In the UK and Ireland, the Company has a direct sales team selling Inspiration Branded and complementary products from third parties, with an additional range of home healthcare products. This is supported by Technical Support for planned preventative maintenance and emergency assistance.
Further information on Inspiration Healthcare can be seen at www.inspirationhealthcaregroup.plc.uk